The role of capsid protein nucleolar localisation in chikungunya virus: implications for vaccine development [ 2017 - ]

Research Grant

Researchers: Dr Adam Taylor (Principal investigator)

Brief description Chikungunya virus (CHIKV) is a globally widespread mosquito-borne alphavirus capable of causing considerable human morbidity and mortality. With no CHIKV vaccine or antiviral available this proposal aims to develop a live attenuated CHIKV vaccine, rationally designed by investigating the host cell nucleolar trafficking of CHIKV capsid protein. This vaccine has the potential to provide cross-protection against additional arthritogenic alphaviruses endemic to Australia such as Ross River virus.

Funding Amount $520,520.00

Funding Scheme Project Grants

Notes New Investigator Grant